美国预防服务工作组(USPSTF)列出了32项A级或B级推荐的非孕美国成年人预防性服务，包括结直肠癌筛查。然而，在初级保健中，对如何一致和忠诚地实施这些服务几乎没有给出指导。鉴于患者访问时间有限且需求竞争激烈，初级保健提供者(PCPs)倾向于优先考虑其中的一小部分建议。其中一些服务的完成率，包括结直肠癌筛查，不够理想。将预防性服务扩大到其他医疗机构可能会改善医疗资源匮乏地区或人群的接触和使用。无需PCP参与，可有配药师将结直肠癌筛查的粪便免疫化学检测(FIT)(在家使用的基于粪便的检测)分发和处理。配药师长期以来一直提供预防性服务(如流感疫苗接种)，可能是利用FIT扩大结直肠癌筛查的良好选择，但不清楚PCP如何看待此扩大。本研究使用了北卡罗来纳州和华盛顿州的PCPs半结构化访谈，以评估对潜在药房分发FIT方案(PharmFIT™)的看法和建议。对访谈记录进行编码和分析，使用整合实施研究框架(CFIR)引导的混合归纳-演绎内容分析，以阐明PharmFIT™实施的潜在多层面推动因素和障碍。我们在北卡罗来纳州(N=12)和华盛顿州(N=18)的PCPs完成了30个访谈。两个州的PCPs普遍对PharmFIT™持认可态度，但有几个重要考虑。首先，PCPs认为配药师应接受适当的培训，以识别适合和应进行FIT筛查的患者。其次，应明确责任，确立追踪测试、沟通以及尤其是阳性测试结果的后续工作，并且应予以遵守。最后，应建立明确的电子工作流程，用于药房与初级保健诊所之间传递测试结果信息。如果满足配药师培训、阳性FIT随访和文件传递的条件，PCPs可能会支持PharmFIT™作为患者获取和完成FIT筛查的方式。© 2023. BioMed Central Ltd., Springer Nature的一部分。

The United States Preventive Services Task Force (USPSTF) lists 32 grade A or B recommended preventive services for non-pregnant United States (US) adults, including colorectal cancer screening (CRC). Little guidance is given on how to implement these services with consistency and fidelity in primary care. Given limited patient visit time and competing demands, primary care providers (PCPs) tend to prioritize a small subset of these recommendations. Completion rates of some of these services, including CRC screening, are suboptimal. Expanding delivery of preventive services to other healthcare providers, where possible, can improve access and uptake, particularly in medically underserved areas or populations. Fecal immunochemical testing (FIT) (at-home, stool-based testing) for CRC screening can be distributed and resulted without PCP involvement. Pharmacists have long delivered preventive services (e.g., influenza vaccination) and may be a good option for expanding CRC screening delivery using FIT, but it is not clear how PCPs would perceive this expansion.We used semi-structured interviews with PCPs in North Carolina and Washington state to assess perceptions and recommendations for a potential pharmacy-based FIT distribution program (PharmFIT™). Transcripts were coded and analyzed using a hybrid inductive-deductive content analysis guided by the Consolidated Framework for Implementation Research (CFIR) to elucidate potential multi-level facilitators of and barriers to implementation of PharmFIT™.We completed 30 interviews with PCPs in North Carolina (N = 12) and Washington state (N = 18). PCPs in both states were largely accepting of PharmFIT™, with several important considerations. First, PCPs felt that pharmacists should receive appropriate training for identifying patients eligible and due for FIT screening. Second, a clear understanding of responsibility for tracking tests, communication, and, particularly, follow-up of positive test results should be established and followed. Finally, clear electronic workflows should be established for relay of test result information between the pharmacy and the primary care clinic.If the conditions are met regarding pharmacist training, follow-up for positive FITs, and transfer of documentation, PCPs are likely to support PharmFIT™ as a way for their patients to obtain and complete CRC screening using FIT.© 2023. BioMed Central Ltd., part of Springer Nature.